Weak protein interactions and pH- and temperature-dependent aggregation of human Fc1

References

• Ecker DM, Jones SD, Levine HL. The therapeutic monoclonal antibody market. MAbs 2015; 7:9-14; PMID:25529996; http://dx.doi.org/10.4161/19420862.2015.989042
   PubMed Web of Science ®Google Scholar
• Aggarwal S. What's fueling the biotech engine - 2012 to 2013. Nat Biotechnol 2014; 32:32-9; PMID:24406926; http://dx.doi.org/10.1038/nbt.2794
   PubMed Web of Science ®Google Scholar
• Carter P. Introduction to current and future protein therapeutics: a protein engineering perspective. Exp Cell Res 2011; 317:1261-9; PMID:21371474; http://dx.doi.org/10.1016/j.yexcr.2011.02.013
   PubMed Web of Science ®Google Scholar
• Kontermann R, Brinkmann U. Bispecific antibodies. Drug Discov Today 2015; 0:1-10
   Google Scholar
• Beck A, Reichert J. Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies. mAbs 2011; 3:415-6; PMID:21785279; http://dx.doi.org/10.4161/mabs.3.5.17334
   PubMed Web of Science ®Google Scholar
• Rath T, Baker K, Dumont J, Peters R, Jiang H, Qiao S, Lencer W, Pierce G, Blumberg R. Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics. Crit Rev Biotechnol 2015; 35:235-54; PMID:24156398; http://dx.doi.org/10.3109/07388551.2013.834293
   PubMed Web of Science ®Google Scholar
• Levin D, Golding B, Strome S, Sauna Z. Fc fusion as a platform technology: potential for modulating immunogenicity. Trends Biochem Sci 2015; 33:27-34
   Google Scholar
• Kontermann R. Strategies to extend plasma half-lives of recombinant antibodies. BioDrugs 2009; 23:93-109; PMID:19489651; http://dx.doi.org/10.2165/00063030-200923020-00003
   PubMed Web of Science ®Google Scholar
• Braun A, Kwee L, Labow M, Alsenz J. Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon α (IFN-α) in normal and transgenic mice. Pharm Res 1997; 14:1472-8; PMID:9358564; http://dx.doi.org/10.1023/A:1012193326789
   PubMed Web of Science ®Google Scholar
• Schellekens H. Bioequivalence and the immunogenicity of biopharmaceuticals. Nat Rev 2002; 1:457-62
   Google Scholar
• Ratanji K, Derrick J, Dearman R, Kimber I. Immunogenicity of therapeutic proteins: Influence of aggregation. J Immunotoxicol 2014; 11:99-109; PMID:23919460; http://dx.doi.org/10.3109/1547691X.2013.821564
   PubMed Web of Science ®Google Scholar
• Wu H, Kroe-Barrett R, Singh S, Robinson A, Roberts C. Competing aggregation pathways for monoclonal antibodies. FEBS Lett 2014; 588:936-41; PMID:24530501; http://dx.doi.org/10.1016/j.febslet.2014.01.051
   PubMed Web of Science ®Google Scholar
• Weiss IV W, Young T, Roberts C. Principles, approaches, and challenges for predicting protein aggregation rates and shelf life. J Pharm Sci 2009; 98:1246-77; PMID:18683878; http://dx.doi.org/10.1002/jps.21521
   PubMed Web of Science ®Google Scholar
• Kumar S, Wang X, Singh S. Identification and impact of aggregation-prone regions in proteins and therapeutic monoclonal antibodies. In: Aggregation of therapeutic proteins. Hoboken, NJ: John Wiley & Sons, Inc; 2011; 103-15
   Google Scholar
• Zhong X, Wright J. Biological insights into therapeutic protein modifications throughout trafficking and their biopharmaceutical applications. Int J Cell Biol 2013; 2013: Article ID 273086; 1-15; PMID:23690780; http://dx.doi.org/10.1155/2013/273086
   PubMedGoogle Scholar
• Kim H, Yamaguchi Y, Masuda K, Matsunaga C, Yamamoto K, Irimura T, Takahashi N, Kato K, Arata Y. O-glycosylation in hinge region of mouse immunoglobulin G2b. J Biol Chem 1994; 269:12345-50; PMID:7512967
   PubMed Web of Science ®Google Scholar
• Liu H, Gaza-Bulseco G, Faldu D, Chumsae C, Sun J. Heterogeneity of monoclonal antibodies. J Pharm Sci 97:2426-47; PMID:17828757; http://dx.doi.org/10.1002/jps.21180
   PubMed Web of Science ®Google Scholar
• Demarest S, Rogers J, Hansen G. Optimization of the antibody CH3 domain by residue frequency analysis of IgG sequences. J Mol Biol 2004; 335:41-8; PMID:14659738; http://dx.doi.org/10.1016/j.jmb.2003.10.040
   PubMed Web of Science ®Google Scholar
• Souillac P. Biophysical characterization of insoluble aggregates of a multi-domain protein: an insight into the role of the various domains. J Pharm Sci 2005; 94:2069-83; PMID:16052560; http://dx.doi.org/10.1002/jps.20423
   PubMed Web of Science ®Google Scholar
• Ionescu R, Vlasak J, Price C, Kirchmeier M. Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies. J Pharm Sci 2008; 97:1414-26; PMID:17721938; http://dx.doi.org/10.1002/jps.21104
   PubMed Web of Science ®Google Scholar
• Roberts C. Non-native protein aggregation kinetics. Biotechnol Bioeng 2007; 98:9237-8; http://dx.doi.org/10.1002/bit.21627
   Web of Science ®Google Scholar
• Roberts C. Kinetics of irreversible protein aggregation: analysis of extended Lumry-Eyring models and implications for predicting protein shelf life. J Phys Chem B 2003; 107:1194-207; http://dx.doi.org/10.1021/jp026827s
   Web of Science ®Google Scholar
• Andrews J, Roberts C. A Lumry-Eyring nucleation polymerization model of protein aggregation kinetics: 1. aggregation with pre-equilibrated unfolding. J Phys Chem B 2007; 111:7897-913; PMID:17571872; http://dx.doi.org/10.1021/jp070212j
   PubMed Web of Science ®Google Scholar
• Andrews J, Roberts C. Non-native aggregation of α-Chymotrypsinogen occurs through nucleation and growth with competing nucleus sizes and negative activation energies. Biochemistry (Mosc) 2007; 46:7558-71; http://dx.doi.org/10.1021/bi700296f
   Web of Science ®Google Scholar
• Voet D, Voet JG. Biochemistry (3rd ed). Hoboken, NJ: John Wiley and Sons, Inc; 2004
   Google Scholar
• Brown P, Schuck P. Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation. Biophys J 2006; 90:4651-61; PMID:16565040; http://dx.doi.org/10.1529/biophysj.106.081372
   PubMed Web of Science ®Google Scholar
• Chase S, Laue T. The determination of protein valence by capillary electrophoresis. PACE Setter 2008; 12:1-5
   Google Scholar
• Edsall J, Wyman J. Biophysical Chemistry: Volume 1 (1st ed.). San Diego, CA: Academic Press; 1958; 282-95
   Google Scholar
• Henry D. The cataphoresis of suspended particles. Proc Roy Soc A 1931; 133:106-40; http://dx.doi.org/10.1098/rspa.1931.0133
   Google Scholar
• Kertes A, King C. Extraction chemistry of fermentation product carboxylic-acids. Biotechnol Bioeng 1986; 28:269-82; PMID:18555324; http://dx.doi.org/10.1002/bit.260280217
   PubMed Web of Science ®Google Scholar
• Blanco M, Sahin E, Li Y, Roberts C. Reexamining protein-protein and protein-solvent interactions from Kirkwood-Buff analysis of light scattering in multi-component solutions. J Chem Phys 2011; 134:225103-12; PMID:21682538; http://dx.doi.org/10.1063/1.3596726
   PubMed Web of Science ®Google Scholar
• Blanco M, Perevozchikova T, Martorana V, Manno M, Roberts C. Protein-protein interactions in dilute to concentrated solutions: α-chymotrypsinogen in acidic conditions. J Phys Chem B 2014; 118:5817-31; PMID:24810917; http://dx.doi.org/10.1021/jp412301h
   PubMed Web of Science ®Google Scholar
• Brummitt R, Nesta D, Chang L, Chase S, Laue T, Roberts C. Nonnative aggregation of an IgG1 antibody in acidic conditions: Part 1. unfolding, colloidal interactions, formation of high-molecular-weight aggregates. J Pharm Sci 2011; 100:2087-103; PMID:21213308; http://dx.doi.org/10.1002/jps.22448
   PubMed Web of Science ®Google Scholar
• Kim N, Remmele R Jr., Liu D, Razinkov V, Fernandez E, Roberts C. Aggregation of anti-streptavidin immunoglobulin gamma-1 involves Fab unfolding and competing growth pathways mediated by pH and salt concentration. Biophys Chem 2013; 172:26-36; PMID:23334430; http://dx.doi.org/10.1016/j.bpc.2012.12.004
   PubMed Web of Science ®Google Scholar
• Sahin E, Grillo A, Perkins M, Roberts C. Comparative effects of pH and ionic strength on protein-protein interactions, unfolding, and aggregation for IgG1 antibodies. J Pharm Sci 2010; 99:4830-48; PMID:20821389; http://dx.doi.org/10.1002/jps.22198
   PubMed Web of Science ®Google Scholar
• Li Y, Roberts C. A Lumry-Eyring nucleated-polymerization model of protein aggregation kinetics 2. Competing growth via condensation and chain polymerization. J Phys Chem B 2009; 113:7020-32; PMID:19368365; http://dx.doi.org/10.1021/jp8083088
   PubMed Web of Science ®Google Scholar
• Li Y, Weiss IV W, Roberts C. Characterization of high-molecular-weight nonnative aggregates and aggregation kinetics by size exclusion chromatography with inline multi-angle laser light scattering. J Pharm Sci 2009; 98:3997-4016; PMID:19283773; http://dx.doi.org/10.1002/jps.21726
   PubMed Web of Science ®Google Scholar
• Brummitt R, Nesta D, Chang L, Kroetsch A, Roberts C. Nonnative aggregation of an IgG1 antibody in acidic conditions, Part 2: nucleation and growth kinetics with competing growth mechanisms. J Pharm Sci 2011; 100:2104-19; PMID:21213307; http://dx.doi.org/10.1002/jps.22447
   PubMed Web of Science ®Google Scholar
• Li Y, Ogunnaike B, Roberts C. Multi-variate approach to global protein aggregation behavior and kinetics: Effects of pH, NaCl, and temperature for α-chymotrypsinogen A. J Pharm Sci 2010; 99:645-62; PMID:19653264; http://dx.doi.org/10.1002/jps.22159
   PubMed Web of Science ®Google Scholar
• Santora L, Krull I, Grant K. Characterization of recombinant human monoclonal tissue necrosis factor-α antibody using cation-exchange HPLC and capillary isoelectric focusing. Anal Biochem 1999; 275:98-108; PMID:10542114; http://dx.doi.org/10.1006/abio.1999.4275
   PubMed Web of Science ®Google Scholar
• Santora L, Stanley K, Krull I, Grant K. Characterization of maleuric acid derivatives on transgenic human monoclonal antibody due to post-secretional modifications in goat milk. Biomed Chromatogr 2006; 20:843-56; PMID:16425344; http://dx.doi.org/10.1002/bmc.603
   PubMed Web of Science ®Google Scholar
• Lyubarskaya Y, Houde D, Woodard J, Murphy D, Mhatre R. Analysis of recombinant monoclonal antibody isoforms by electrospray ionization mass spectrometry as a strategy for streamlining characterization of recombinant monoclonal antibody charge heterogeneity. Anal Biochem 2006; 348:24-39; PMID:16289440; http://dx.doi.org/10.1016/j.ab.2005.10.003
   PubMed Web of Science ®Google Scholar
• Garber E, Demarest S. A broad range of Fab stabilities within a host of therapeutic IgGs. Biochem Biophys Res Commun 2007; 355:751-7; PMID:17321501; http://dx.doi.org/10.1016/j.bbrc.2007.02.042
   PubMed Web of Science ®Google Scholar
• McConnell A, Spasojevich V, Macomber J, Krapf I, Chen A, Sheffer J, Berkebile A, Horlick R, Neben S, King D, et al. An integrated approach to extreme thermostabilization and affinity maturation of an antibody. Protein Eng Des Sel 2013; 26:151-63; PMID:23173178; http://dx.doi.org/10.1093/protein/gzs090
   PubMed Web of Science ®Google Scholar
• Latypov R, Hogan S, Lau H, Gadgil H, Liu D. Elucidation of acid-induced unfolding and aggregation of human immunoglobulin IgG1 and IgG2 Fc. J Biol Chem 2012; 287:1381-96; PMID:22084250; http://dx.doi.org/10.1074/jbc.M111.297697
   PubMed Web of Science ®Google Scholar
• Vermeer A, Norde W. The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein. Biophys J 2000; 78:394-404; PMID:10620303; http://dx.doi.org/10.1016/S0006-3495(00)76602-1
   PubMed Web of Science ®Google Scholar
• Ahmed A, Giddens J, Pincetic A, Lomino J, Ravetch J, Wang L, Bjorkman P. Structural characterization of anti-inflammatory immunoglobulin G Fc proteins. J Mol Biol 2014; 426:3166-79; PMID:25036289; http://dx.doi.org/10.1016/j.jmb.2014.07.006
   PubMed Web of Science ®Google Scholar
• Barnett G, Razinkov V, Kerwin B, Laue T, Woodka A, Butler P, Perevozchikova T, Roberts C. Specific-ion effects on the aggregation mechanisms and protein-protein interactions for anti-streptavidin immunoglobulin gamma-1. J Phys Chem B 2015; 119:5793-804; PMID:25885209; http://dx.doi.org/10.1021/acs.jpcb.5b01881
   PubMed Web of Science ®Google Scholar
• Ben-Naim A. Statistical thermodynamics for chemists and biochemists (1st ed.). New York, NY: Plenum Press; 1992
   Google Scholar
• McQuarrie D. Statistical mechanics (2nd ed.). Sausalito, CA: University Science Books; 2000
   Google Scholar
• Israelachvili J. Intermolecular & surface forces (2nd ed.). London, UK: Academic Press; 1992
   Google Scholar
• Roberts D, Keeling R, Tracka M, van der Walle C, Uddin S, Warwicker J, Curtis R. The role of electrostatics in protein-protein interactions of a monoclonal antibody. Mol Pharm 2014; 11:2475-89; PMID:24892385; http://dx.doi.org/10.1021/mp5002334
   PubMed Web of Science ®Google Scholar
• Tessier P, Sandler S, Lenhoff A. Direct measurement of protein osmotic second virial coefficients by cross-interaction chromatography. Protein Sci 2004; 13:1379-90; PMID:15075404; http://dx.doi.org/10.1110/ps.03419204
   PubMed Web of Science ®Google Scholar
• Arosio P, Jaquet B, Wu H, Morbidelli M. On the role of salt type and concentration on the stability behavior of a monoclonal antibody solution. Biophys Chem 2012; 168–169:19-27; PMID:22750560; http://dx.doi.org/10.1016/j.bpc.2012.05.004
   PubMed Web of Science ®Google Scholar
• Drenski M, Brader M, Alston R, Reed W. Monitoring protein aggregation kinetics with simultaneous multiple sample light scattering. Anal Biochem 2013; 437:185-97; PMID:23481914; http://dx.doi.org/10.1016/j.ab.2013.02.014
   PubMed Web of Science ®Google Scholar
• Roberts C, Darrington R. Irreversible aggregation of recombinant bovine granulocyte-colony stimulating factor (bG-CSF) and implications for predicting protein shelf life. J Pharm Sci 2003; 92:1095-111; PMID:12712430; http://dx.doi.org/10.1002/jps.10377
   PubMed Web of Science ®Google Scholar
• Wang W, Roberts C. Non-Arrhenius protein aggregation. AAPS J 2013; 15:840-51; PMID:23615748; http://dx.doi.org/10.1208/s12248-013-9485-3
   PubMed Web of Science ®Google Scholar
• Kayser V, Chennamsetty N, Voynov V, Helk B, Forrer K, Trout BL. Evaluation of a Non-Arrhenius model for therapeutic monoclonal antibody aggregation. J Pharm Sci 2011; 100:2526-42; PMID:21268027; http://dx.doi.org/10.1002/jps.22493
   PubMed Web of Science ®Google Scholar
• Saluja A, Sadineni V, Mungikar A, Nashine V, Kroetsch A, Dahlheim C, Rao VM. Significance of unfolding thermodynamics for predicting aggregation kinetics: A case study on high concentration solutions of a multi-domain protein. Pharm Res 2014; 31:1575-87; PMID:24398696; http://dx.doi.org/10.1007/s11095-013-1263-5
   PubMed Web of Science ®Google Scholar
• Cole J, Lary J, Moody T, Laue T. Analytical ultracentrifugation: sedimentation velocity and sedimentation equilibrium. Methods Cell Biol 2008; 84:143-79; PMID:17964931; http://dx.doi.org/10.1016/S0091-679X(07)84006-4
   PubMed Web of Science ®Google Scholar
• Schuck P, Perugini M, Gonzales N, Howlett G, Schubert D. Size-distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model systems. Biophys J 2002; 82:1096-111; PMID:11806949; http://dx.doi.org/10.1016/S0006-3495(02)75469-6
   PubMed Web of Science ®Google Scholar
• Harding S, Rowe A, Horton J. Analytical ultracentrifugation in biochemistry and polymer science (1st ed.). London, UK: Royal Society of Chemistry; 1992
   Google Scholar
• Adamson N, Reynolds E. Rules relating electrophoresis mobility, charge, and molecular size of peptides and proteins. J Chromatogr B 1997; 699:133-47; http://dx.doi.org/10.1016/S0378-4347(97)00202-8
   PubMed Web of Science ®Google Scholar